-
13183-5A selective inhibitor of PDE4 (IC<sub>50</sub> = 1.27 &muM for PDE4 versus >100 &muM for PDE1, PDE2, PDE3, and PDE5) inhibits eosinophil superoxide production (IC<sub>50</sub> induced TNF&alpha release from monocytes, (IC<sub>50</sub> = 0.
-
13183-500A selective inhibitor of PDE4 (IC<sub>50</sub> = 1.27 &muM for PDE4 versus >100 &muM for PDE1, PDE2, PDE3, and PDE5) inhibits eosinophil superoxide production (IC<sub>50</sub> induced TNF&alpha release from monocytes, (IC<sub>50</sub> = 0.
-
11955-1CP 945,598 (hydrochloride) is a selective antagonist of the cannabinoid receptor CB<sub>1</sub> with a Ki value of 0.7 nM and demonstrates relatively low affinity for CB<sub>2</sub> receptors (Ki = 7.
-
11955-10CP 945,598 (hydrochloride) is a selective antagonist of the cannabinoid receptor CB<sub>1</sub> with a Ki value of 0.7 nM and demonstrates relatively low affinity for CB<sub>2</sub> receptors (Ki = 7.
-
11955-25CP 945,598 (hydrochloride) is a selective antagonist of the cannabinoid receptor CB<sub>1</sub> with a Ki value of 0.7 nM and demonstrates relatively low affinity for CB<sub>2</sub> receptors (Ki = 7.
-
11955-5CP 945,598 (hydrochloride) is a selective antagonist of the cannabinoid receptor CB<sub>1</sub> with a Ki value of 0.7 nM and demonstrates relatively low affinity for CB<sub>2</sub> receptors (Ki = 7.
-
20473-1Molecular Formula: C<sub>26</sub>H<sub>24</sub>ClFN<sub>4</sub>O &bull C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>
-
20473-10Molecular Formula: C<sub>26</sub>H<sub>24</sub>ClFN<sub>4</sub>O &bull C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>
-
20473-5Molecular Formula: C<sub>26</sub>H<sub>24</sub>ClFN<sub>4</sub>O &bull C<sub>4</sub>H<sub>4</sub>O<sub>4</sub>
-
75500-10A divalent crosslinker of SAP that causes rapid depletion of circulating SAP via hepatic clearance.
-
75500-5A divalent crosslinker of SAP that causes rapid depletion of circulating SAP via hepatic clearance.
-
75500-50A divalent crosslinker of SAP that causes rapid depletion of circulating SAP via hepatic clearance.